Lomustine

Drug Overview

Lomustine is a powerful, traditional chemotherapy medicine used to treat specific types of cancer. While it does not have “Smart Drug,” “Targeted Therapy,” or “Immunotherapy” characteristics, it has a very special and rare ability. It can easily cross the blood-brain barrier, which is the body’s natural shield that protects the brain. This makes it an essential tool for fighting brain tumors.

• Generic name: Lomustine (also known as CCNU)
• US Brand names: Gleostine
• Drug Class: Alkylating agent (Nitrosourea)
• Route of Administration: Oral (taken by mouth as a capsule)
• FDA Approval Status: Fully approved by the US Food and Drug Administration.

What Is It and How Does It Work? (Mechanism of Action)

Lomustine belongs to a family of chemotherapy drugs called nitrosoureas. To understand how it works, it helps to look at what cancer cells do best: they divide and multiply rapidly by copying their DNA.

Here is how lomustine works at the molecular level to stop this process:

Because this medicine is highly fat-soluble, it easily passes through the protective fat layers of the brain and enters the cancer cells. Once inside the cell, lomustine breaks down into active chemical pieces and performs a two-part attack.

First, it acts as an alkylating agent. It attaches chemical tags, called alkyl groups, directly to the DNA of the cancer cell. This creates a tight, unnatural bridge between the two strands of DNA, known as a cross-link. Because the DNA is glued together, the cell cannot unzip it to read its instructions or make copies of itself.

Second, it performs a process called carbamylation. The medicine attaches to important proteins and enzymes inside the cell, specifically the enzymes that the cell normally uses to repair damaged DNA. By breaking the DNA and destroying the cell’s repair tools at the same time, the cancer cell becomes hopelessly damaged and triggers its own natural death cycle, a process called apoptosis.

FDA-Approved Clinical Indications

Lomustine is a proven treatment and has official FDA approval for the following uses.

Oncological uses:

• Brain tumors: Used for both primary brain tumors (like glioblastoma and astrocytoma) and metastatic brain tumors (cancer that has spread to the brain from other parts of the body).
• Hodgkin lymphoma: Used as a secondary therapy when other main treatments have stopped working.

Non oncological uses:

• None at this time.

Dosage and Administration Protocols

Unlike many chemotherapy drugs given through a vein, lomustine is a capsule taken by mouth at home or in the clinic. Because the drug stays in the body and affects the bone marrow for a long time, the dosing schedule is very spaced out.

Important note: A new dose cannot be given until the patient’s white blood cell and platelet counts have fully recovered to safe levels.

Clinical Efficacy and Research Results

Recent clinical studies from 2020 to 2025 continue to show the importance of lomustine, especially for difficult brain cancers like glioblastoma.

When glioblastoma returns after initial treatment, lomustine is often used as the standard of care. In recent studies looking at recurrent glioblastoma, patients taking lomustine alone or combined with other drugs like bevacizumab experienced an average overall survival of 7 to 9 months, with the disease stopped from growing for an average of 1.5 to 4 months.

For newly diagnosed brain tumors, scientists have found that testing the tumor’s genetics makes a big difference. In recent trials for patients with a specific genetic marker called an MGMT methylated promoter, combining lomustine with another drug called temozolomide showed massive improvements. In these specific groups, long-term data showed average survival rates extending beyond 30 to 40 months, which is a significant increase compared to older standard therapies.

Safety Profile and Side Effects

Because lomustine is a strong traditional chemotherapy, it affects both cancer cells and healthy cells, leading to side effects.

Black Box Warning:

Lomustine carries a strict FDA Black Box Warning for delayed bone marrow suppression. This means the drug dangerously lowers white blood cells (which fight infection) and blood platelets (which stop bleeding). Unlike most drugs, this severe drop happens very late, usually 4 to 6 weeks after taking the pill. The warning also states that doctors and pharmacists must only dispense one dose at a time to prevent accidental, fatal overdoses.

Common side effects (Occurring in greater than 10 percent of patients):

• Severe nausea and vomiting (happens in almost all patients if not prevented).
• Delayed drop in white blood cells and platelets.
• Feeling extremely tired and weak.
• Loss of appetite.
• Temporary hair thinning or loss.

Serious adverse events:

• Pulmonary toxicity: Scarring of the lungs that can cause permanent breathing problems.
• Nephrotoxicity: Severe kidney damage.
• Hepatotoxicity: Liver damage.
• Secondary cancers: A small risk of developing blood cancers, like leukemia, years after treatment.

Management strategies:

To handle the severe nausea, doctors prescribe strong anti-nausea medicines to be taken before swallowing the lomustine capsule. Because of the delayed bone marrow suppression, patients must get weekly blood tests starting two weeks after taking their dose. If blood counts drop too low, the doctor will lower the dose for the next 6-week cycle. Lung function is also tested regularly to catch any early signs of scarring.

Connection to Stem Cell and Regenerative Medicine (If Applicable)

Research Areas:

While lomustine is a traditional chemotherapy, it is heavily used in the field of regenerative medicine, specifically during autologous stem cell transplants for severe lymphomas. Because high doses of lomustine can destroy the bone marrow, doctors use a regenerative rescue strategy. First, they safely collect and freeze the patient’s healthy blood stem cells. Then, they give massive doses of lomustine and other drugs to wipe out the cancer. Finally, they return the thawed stem cells to the patient’s body to regenerate a brand new, healthy immune and blood system.

Patient Management and Practical Recommendations

Taking chemotherapy at home requires strict rules to keep the patient safe.

Pre-treatment tests to be performed:

• Complete blood count tests.
• Lung function tests (pulmonary function tests).
• Baseline kidney and liver blood tests.

Precautions during treatment:

• Only handle the capsules with clean, dry hands, or wear gloves. Caregivers who are pregnant must never touch this medicine.
• Avoid people who are sick, sneezing, or coughing, especially 4 to 6 weeks after your dose when your immune system is at its weakest.

Do’s and Don’ts list:

• Do take the capsule on an empty stomach to help prevent vomiting.
• Do take your anti-nausea medicine exactly as your doctor tells you to before taking your dose.
• Do drink plenty of water to help protect your kidneys.
• Do contact your doctor immediately if you develop a fever, chills, or unusual bruising a month after taking your pill.
• Do not take this medicine more than once every 6 weeks.
• Do not get any live vaccines without talking to your oncologist first.
• Do not take over-the-counter pain medicines like ibuprofen or aspirin without asking your doctor, as they can increase your risk of bleeding.

Legal Disclaimer

The medical information provided in this guide is for educational and informational purposes only and is not meant to replace professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment options. Do not disregard professional medical advice or delay seeking it because of something you have read in this material.